Urteste S.A. (URT.WA)

PLN 92.8

(-1.28%)

Total Liabilities Summary of Urteste S.A.

  • Urteste S.A.'s latest annual total liabilities in 2023 was 1.85 Million PLN , up 72.88% from previous year.
  • Urteste S.A.'s latest quarterly total liabilities in 2024 Q2 was 2.65 Million PLN , up 46.81% from previous quarter.
  • Urteste S.A. reported annual total liabilities of 1.07 Million PLN in 2022, up 325.72% from previous year.
  • Urteste S.A. reported annual total liabilities of 252.04 Thousand PLN in 2021, up 1284.4% from previous year.
  • Urteste S.A. reported quarterly total liabilities of 2.65 Million PLN for 2024 Q2, up 46.81% from previous quarter.
  • Urteste S.A. reported quarterly total liabilities of 1.02 Million PLN for 2023 Q1, down -4.47% from previous quarter.

Annual Total Liabilities Chart of Urteste S.A. (2023 - 2019)

Historical Annual Total Liabilities of Urteste S.A. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 1.85 Million PLN 72.88%
2022 1.07 Million PLN 325.72%
2021 252.04 Thousand PLN 1284.4%
2020 18.2 Thousand PLN -58.64%
2019 44.02 Thousand PLN 0.0%

Peer Total Liabilities Comparison of Urteste S.A.

Name Total Liabilities Total Liabilities Difference
Bioceltix S.A. 2.26 Million PLN 18.231%
BIOTON S.A. 215.86 Million PLN 99.141%
Captor Therapeutics Spolka Akcyjna 28.07 Million PLN 93.392%
Mabion S.A. 90.47 Million PLN 97.95%
Molecure S.A. 11.34 Million PLN 83.649%
NanoGroup S.A. 1.49 Million PLN -24.489%
Pharmena S.A. 1.9 Million PLN 2.676%
Poltreg S.A. 39.58 Million PLN 95.313%
Pure Biologics Spólka Akcyjna 20.84 Million PLN 91.101%
Ryvu Therapeutics S.A. 120.36 Million PLN 98.459%
Synthaverse S.A. 153.26 Million PLN 98.79%